Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Shares Outstanding (2019 - 2025)

Bioadaptives' Shares Outstanding history spans 7 years, with the latest figure at $158508.0 for Q3 2025.

  • For Q3 2025, Shares Outstanding fell 84.15% year-over-year to $158508.0; the TTM value through Sep 2025 reached $158508.0, down 84.15%, while the annual FY2024 figure was $1.0 million, 13233.33% up from the prior year.
  • Shares Outstanding for Q3 2025 was $1.0 million at Bioadaptives, up from $9667.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $576.5 million in Q2 2023 and bottomed at $5333.0 in Q4 2022.
  • The 5-year median for Shares Outstanding is $1.6 million (2021), against an average of $38.3 million.
  • The largest annual shift saw Shares Outstanding plummeted 99.55% in 2023 before it surged 88990.4% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $1.6 million in 2021, then grew by 5.23% to $1.7 million in 2022, then crashed by 99.55% to $7500.0 in 2023, then soared by 869.16% to $72687.0 in 2024, then surged by 118.07% to $158508.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Shares Outstanding are $158508.0 (Q3 2025), $9.9 million (Q2 2025), and $9667.0 (Q1 2025).